NCT04336969

Brief Summary

The 4T program encompasses: Teamwork, Targets, Technology, and Tight Range. These methods will help patients better manage their condition of Type 1 Diabetes with improved patient-reported outcomes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
316

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jun 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 3, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

April 7, 2020

Completed
2 months until next milestone

Study Start

First participant enrolled

June 18, 2020

Completed
5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2025

Completed
Last Updated

March 3, 2026

Status Verified

March 1, 2025

Enrollment Period

5 years

First QC Date

April 3, 2020

Last Update Submit

February 27, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in rise of HbA1c

    Rise in HbA1c (a measure of blood sugar levels over the previous 3 months) as a measurement of the effect of 4T education and care. Collected through a blood sample.

    Baseline, 6 months and 12 months post-diagnosis

Secondary Outcomes (11)

  • Change in CGM Benefits and Burden Scale

    Baseline, 3, 6, 9 and 12 months

  • Change Diabetes Distress Scale

    Baseline, 3, 6, 9 and 12 months

  • Change in Diabetes Technology Attitude Scale

    Baseline, 3, 6, 9 and 12 months

  • Change in Parental Diabetes Distress Scale

    Baseline, 3, 6, 9 and 12 months

  • Change in Promise Global Health Scale

    Baseline, 3, 6, 9 and 12 months

  • +6 more secondary outcomes

Other Outcomes (1)

  • T1D Patients receiving 4T education and care monitored on a step-down cadence in study 2, will achieve an HBA1c non-inferior to weekly review

    4-12 month trajectory in study 2

Study Arms (1)

T1D Patients

OTHER

Participants will wear a Continuous Glucose Monitor (CGM) with remote data monitoring

Behavioral: 4T Education and Care

Interventions

CGM data will be used to create customized weekly or monthly feedback to the participant/family by secure MyChart message.

T1D Patients

Eligibility Criteria

Age6 Months - 21 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • All individuals within one month of T1D diagnosis seen at the Stanford Children's Diabetes Clinic
  • Individuals who plan to receive follow up care at the Stanford Children's Diabetes Clinic
  • Individuals who agree to CGM data integration into the EMR for remote monitoring
  • Age: six months to \< 21 years of age
  • Patient or guardian must own and operate an Apple compatible device (e.g., iPhone or iPod Touch) to allow for the Dexcom app and CGM data transmission to the hospital server-based remote monitoring system.
  • Dr Prahalad's LPCH Auxiliary Fund grant (in addition to the R18) has resources to support iPod Touch/iPhone purchases for participants who do not have these.
  • o For the Exercise Ancillary study: 11 to \< 21 years of age (the activity tracker is not validated for younger children) English and Spanish-Speaking (Study 2)

You may not qualify if:

  • Diabetes diagnosis other than T1D
  • Diagnosis of diabetes \> one month prior to initial visit
  • Individuals with the intention of obtaining diabetes care at another clinic
  • Individuals who do not consent to CGM use, CGM data integration, remote monitoring
  • Individuals \> 21 years of age

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Franziska Katherine Bishop

Steamboat Springs, Colorado, 80487, United States

Location

Related Publications (6)

  • Prahalad P, Scheinker D, Desai M, Ding VY, Bishop FK, Lee MY, Ferstad J, Zaharieva DP, Addala A, Johari R, Hood K, Maahs DM. Equitable implementation of a precision digital health program for glucose management in individuals with newly diagnosed type 1 diabetes. Nat Med. 2024 Jul;30(7):2067-2075. doi: 10.1038/s41591-024-02975-y. Epub 2024 May 3.

  • Zaharieva DP, Ritter V, Bishop FK, Desai M, Addala A, Prahalad P, Riddell MC, Maahs DM; 4T Study Group. Physical Activity Is Associated With Improved Glycemic Outcomes in Newly Diagnosed Youth With Type 1 Diabetes: 4T Exercise Program. Diabetes Care. 2025 Oct 1;48(10):1752-1760. doi: 10.2337/dc25-0765.

  • Addala A, Ritter V, Schneider-Utaka AK, Alamarie SA, Pang E, Balistreri I, Shaw B, Bishop FK, Zaharieva DP, Prahalad P, Desai M, Maahs DM, Hood KK; 4T Team. Psychosocial outcomes in a diverse sample of youth and their families who initiated continuous glucose monitoring within the first year of type 1 diabetes diagnosis. Diabetes Obes Metab. 2025 Feb;27(2):933-943. doi: 10.1111/dom.16093. Epub 2024 Nov 27.

  • Ferstad JO, Prahalad P, Maahs DM, Zaharieva DP, Fox E, Desai M, Johari R, Scheinker D. Smart Start - Designing Powerful Clinical Trials Using Pilot Study Data. NEJM Evid. 2024 Feb;3(2):EVIDoa2300164. doi: 10.1056/EVIDoa2300164. Epub 2024 Jan 22.

  • Zaharieva DP, Ding VY, Addala A, Prahalad P, Bishop F, Hood KK, Desai M, Wilson DM, Buckingham BA, Maahs DM. Diabetic Ketoacidosis at Diagnosis in Youth with Type 1 Diabetes Is Associated with a Higher Hemoglobin A1c Even with Intensive Insulin Management. Diabetes Technol Ther. 2024 Mar;26(3):176-183. doi: 10.1089/dia.2023.0405.

  • Addala A, Ding V, Zaharieva DP, Bishop FK, Adams AS, King AC, Johari R, Scheinker D, Hood KK, Desai M, Maahs DM, Prahalad P; Teamwork, Targets, Technology, and Tight Control (4T) Study Group. Disparities in Hemoglobin A1c Levels in the First Year After Diagnosis Among Youths With Type 1 Diabetes Offered Continuous Glucose Monitoring. JAMA Netw Open. 2023 Apr 3;6(4):e238881. doi: 10.1001/jamanetworkopen.2023.8881.

Study Officials

  • David M Maahs, MD, PhD

    Lucile Packard Children's Hospital; Stanford University, School of Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief of Pediatric Endocrinology

Study Record Dates

First Submitted

April 3, 2020

First Posted

April 7, 2020

Study Start

June 18, 2020

Primary Completion

July 1, 2025

Study Completion

July 1, 2025

Last Updated

March 3, 2026

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations